Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000467121 | SCV000552316 | benign | Tuberous sclerosis 1 | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575617 | SCV000675401 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-11 | criteria provided, single submitter | clinical testing | The p.R768H variant (also known as c.2303G>A), located in coding exon 16 of the TSC1 gene, results from a G to A substitution at nucleotide position 2303. The arginine at codon 768 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000764812 | SCV000895963 | uncertain significance | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000467121 | SCV002040053 | uncertain significance | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing |